These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38450660)

  • 41. In vitro inhibition of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA by isoniazid.
    Ducasse-Cabanot S; Cohen-Gonsaud M; Marrakchi H; Nguyen M; Zerbib D; Bernadou J; Daffé M; Labesse G; Quémard A
    Antimicrob Agents Chemother; 2004 Jan; 48(1):242-9. PubMed ID: 14693546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, evaluation and in silico molecular modeling of pyrroyl-1,3,4-thiadiazole inhibitors of InhA.
    Joshi SD; More UA; Koli D; Kulkarni MS; Nadagouda MN; Aminabhavi TM
    Bioorg Chem; 2015 Apr; 59():151-67. PubMed ID: 25800133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphorylation of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA regulates mycolic acid biosynthesis.
    Veyron-Churlet R; Zanella-Cléon I; Cohen-Gonsaud M; Molle V; Kremer L
    J Biol Chem; 2010 Apr; 285(17):12714-25. PubMed ID: 20178986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery.
    Prasad MS; Bhole RP; Khedekar PB; Chikhale RV
    Bioorg Chem; 2021 Oct; 115():105242. PubMed ID: 34392175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
    Slayden RA; Lee RE; Barry CE
    Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virtual screening and identification of promising therapeutic compounds against drug-resistant
    Andrianov AM; Furs KV; Gonchar AV; Skrahina AM; Wang Y; Lyu LD; Tuzikov AV
    J Biomol Struct Dyn; 2023 Dec; ():1-13. PubMed ID: 38088766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crystal structure of MabA from Mycobacterium tuberculosis, a reductase involved in long-chain fatty acid biosynthesis.
    Cohen-Gonsaud M; Ducasse S; Hoh F; Zerbib D; Labesse G; Quemard A
    J Mol Biol; 2002 Jul; 320(2):249-61. PubMed ID: 12079383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
    Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of Enoyl-Acyl Carrier Protein Reductase Structure and Interactions Yields an Efficient Virtual Screening Approach and Suggests a Potential Allosteric Site.
    Ghattas MA; Mansour RA; Atatreh N; Bryce RA
    Chem Biol Drug Des; 2016 Jan; 87(1):131-42. PubMed ID: 26259619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of a hybrid genetic system to study the functional relationship between prokaryotic and plant multi-enzyme fatty acid synthetase complexes.
    Kater MM; Koningstein GM; Nijkamp HJ; Stuitje AR
    Plant Mol Biol; 1994 Aug; 25(5):771-90. PubMed ID: 8075395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of Novel Inhibitor of Enoyl-Acyl Carrier Protein Reductase (InhA) Enzyme in
    Singh K; Pandey N; Ahmad F; Upadhyay TK; Islam MH; Alshammari N; Saeed M; Al-Keridis LA; Sharma R
    Antibiotics (Basel); 2022 Aug; 11(8):. PubMed ID: 36009907
    [No Abstract]   [Full Text] [Related]  

  • 52. Novel Hybrid 1,2,4- and 1,2,3-Triazoles Targeting Mycobacterium Tuberculosis Enoyl Acyl Carrier Protein Reductase (InhA): Design, Synthesis, and Molecular Docking.
    El Sawy MA; Elshatanofy MM; El Kilany Y; Kandeel K; Elwakil BH; Hagar M; Aouad MR; Albelwi FF; Rezki N; Jaremko M; El Ashry ESH
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II.
    Brown AK; Papaemmanouil A; Bhowruth V; Bhatt A; Dover LG; Besra GS
    Microbiology (Reading); 2007 Oct; 153(Pt 10):3314-3322. PubMed ID: 17906131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sunflower (Helianthus annuus) fatty acid synthase complex: enoyl-[acyl carrier protein]-reductase genes.
    González-Thuillier I; Venegas-Calerón M; Garcés R; von Wettstein-Knowles P; Martínez-Force E
    Planta; 2015 Jan; 241(1):43-56. PubMed ID: 25204631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD; Mahajan SS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Novel Acyl-AcpM-Binding Protein Confers Intrinsic Sensitivity to Fatty Acid Synthase Type II Inhibitors in
    Li M; Huang Q; Zhang W; Cao Y; Wang Z; Zhao Z; Zhang X; Zhang J
    Front Microbiol; 2022; 13():846722. PubMed ID: 35444621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA).
    Khaleel EF; Sabt A; Korycka-Machala M; Badi RM; Son NT; Ha NX; Hamissa MF; Elsawi AE; Elkaeed EB; Dziadek B; Eldehna WM; Dziadek J
    Bioorg Chem; 2024 Mar; 144():107138. PubMed ID: 38262087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, Synthesis and Pharmacological Evaluation of Some C
    Niveditha N; Begum M; Prathibha D; Sirisha K; Mahender P; Chitra C; Rao VR; Reddy VM; Achaiah G
    Chem Pharm Bull (Tokyo); 2020; 68(12):1170-1177. PubMed ID: 33268649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Type I and type II fatty acid biosynthesis in Eimeria tenella: enoyl reductase activity and structure.
    Lu JZ; Muench SP; Allary M; Campbell S; Roberts CW; Mui E; McLeod RL; Rice DW; Prigge ST
    Parasitology; 2007 Dec; 134(Pt.14):1949-62. PubMed ID: 17697396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.